Skip to Content

'
Krishnakumar Balasubramanian

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Cancer Biology, Division of Basic Science Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Graduate School of Biomedical Sciences, Houston, TX

Research Interests

 

Research Interests Angiogenesis and anti-angiogenic agents, Tumor cell migration and invasion, Apoptotic cell recognition mechanisms, Intracellular calcium signaling during apoptosis and necrosis.

 A.    Anti-angiogenic properties of Beta-2-glycoprotein 1. Several studies have indicated that proteins that participate in thrombosis and fibrinolysis also regulate angiogenesis and expansion of the tumor vasculature, a process crucial for tumor cell survival and proliferation. Many of these “dual function” proteins have typical multidomain, disulfide bridged structures with a single “kringle” motif. Recent published data from our laboratory identified the kringle domain plasma protein, beta-2-glycoprotein 1 (B2GP1), as a negative regulator of angiogenesis. Proteolytic cleavage of intact B2GP1 (IB2GP1) to the nicked isoform (NB2GP1) switched its function from an inhibitor of thrombosis to an inhibitor of endothelial cell (EC) proliferation and blood vessel growth. In vitro, the cleaved protein specifically inhibited the proliferation and migration of EC but not tumor cells. In vivo studies demonstrated that NB2GP1 inhibited neovascularization into subcutaneous gel foam and matrigel implants and, reduced tumor burden in orthotropic mouse tumor models. Importantly, the protein did not affect pre-existing vasculature, suggesting its usefulness as a potent anti-angiogenic and anti-tumor molecule of potential therapeutic significance. Our current research interests are focused on identifying the mechanism for the observed anti-angiogenic activity and evaluating the therapeutic efficacy of NB2GP1 in inhibiting neoangiogenesis and hence, tumor growth and metastasis in various tissue microenvironments.

 B.     Ceramide homeostasis as a regulator of chemo-resistance and metastatic potential. Studies from several laboratories have suggested that resistance to apoptosis is associated with the transtion of primary tumors to an invasive, metastatic phenotype. It is however not clear whether acquisition of resistance is a prerequisite towards metastatic progression of the disease. The mechanisms critical to the transition of cancers from a low-metastatic to a high metastatic phenotype are also not clear. Research over the past several years has demonstrated a direct correlation between elevated levels of the sphingolipid, ceramide, and commitment of cells to apoptosis. Interestingly, ceramide-derived lipids like sphingosine-1-phosphate, sphingomyelin and gangliosides promote cell survival, migration and proliferation, processes that are central to invasion and metastasis. Indeed, recent studies in melanoma and breast cancer revealed an association between expression of proteins regulating sphingolipid metabolism and signaling, and, the propensity to metastasize. This research is currently being developed on the concept that alerted regulation of sphingolipid metabolism and signaling is a crucial determinant of cancer development and progression. It is further hypothesized that resistance to apoptosis in ovarian cancer is an inadvertent and inevitable consequence of depletion in the pro-apoptotic ceramide pools by its metabolism to pro-metastatic signaling molecules that promote survival, proliferation, migration and differentiation. The objective of this research is to use various cancer models to evaluate the potential correlation between the various stages of cancer progression and, differential expression of enzymes/proteins that regulate sphingolipid metabolism and signaling, with the ultimate goal of developing these as biomarkers in early diagnosis.

 C.    Regulation of intracellular calcium homeostasis during programmed cell death. Resistance to apoptosis is one of the major obstacles in the treatment and eradication of cancer. Hence, understanding the mechanisms for resistance is crucial for development of improved therapeutic strategies to combat the disease. Studies from many laboratories have indicated a close interrelationship between cellular metabolism and intracellular Ca2+ homeostasis. Since autophagy and apoptotic response are invariably linked to cellular metabolism and cytosolic Ca2+, it is likely that both resistance to apoptosis and, induction of autophagy might provide a means for protection of metastasizing tumor cells from stress, cytokine and nutrient-deprivation induced apoptosis in a new tissue microenvironment. This research project is currently focused on the role of the ER and the mitochondria in regulating cytosolic Ca2+ and phosphatidylserine externalization (anti-inflammatory phagocyte signal) during tumor cell apoptosis.

Education & Training

Degree-Granting Education

1997 Institute of Microbial Technology, Chandigarh, PHD, Membrane Biology
1989 Indian Institute of Technology, Bombay, MS, Biotechnology
1987 University of Bombay, BS, Chemistry/ Biochemistry

Postgraduate Training

1997-1998 Postdoctoral Fellow, M.D. Anderson Cancer Center, Houston, TX

Experience/Service

Administrative Appointments/Responsibilities

Senator, MDACC Faculty Senate, Department of Cancer Biology, Division of Basic Science Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2008-2011

Selected Publications

Peer-Reviewed Original Research Articles

1. Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Crosstalk between protease-activated receptor 1 (PAR1) and platelet-activating factor receptor (PAFR) regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem, 8/2009. e-Pub 8/2009. PMID: 19703903.
2. Mirnikjoo B, Balasubramanian K, Schroit AJ. Suicidal Membrane Repair Regulates Phosphatidylserine Externalization during Apoptosis. J Biol Chem 284(34):22512-6, 8/2009. e-Pub 6/2009. PMID: 19561081.
3. Mirnikjoo B, Balasubramanian K, Schroit AJ. Mobilization of lysosomal calcium regulates the externalization of phosphatidylserine during apoptosis. J Biol Chem 284(11):6918-23, 3/2009. e-Pub 1/2009. PMCID: PMC2652277.
4. Wolfs JL, Comfurius P, Bekers O, Zwaal RF, Balasubramanian K, Schroit AJ, Lindhout T, Bevers EM.. Direct inhibition of phospholipid scrambling activity in erythrocytes by potassium ions. Cell Mol Life Sci 66(2):314-23, 2009. PMID: 18989619.
5. Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem 283(7):3761-6, 2/2008. PMID: 18073216.
6. *Sakai T, *Balasubramanian K, Maiti S, Halder JB, Schroit AJ. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. Am J Pathol 171(5):1659-69, 11/2007. PMID: 17872974 *equal contribution.
7. Balasubramanian K, Mirnikjoo B, Schroit AJ. Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 282(25):18357-64, 6/2007. PMID: 17470427.
8. Balasubramanian K, Maiti SN, Schroit AJ. Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis 10(2):439-46, 3/2005. PMID: 15843904.

Invited Articles

1. Balasubramanian K, Schroit AJ. Aminophospholipid Asymmetry: A Matter of Life and Death. Annu Rev Physiol 65:701-734, 2003. PMID: 12471163.

Last updated: 9/8/2009